Mayar Capital recently published their Q4 2022 Letter from the Managing Director. Click here to read the full fund letter.Read full newsRead More
Warner Bros. Discovery, Inc. lags behind its competitors in the race for profitability and has a high debt load. Click here for our analysis of WBD.Read full newsRead More
Hesai Group has filed to raise capital via a U.S. IPO. The firm develops and sells LiDAR systems for industries worldwide. Click here for more details about HSAI.Read full newsRead More
Whitecap has outperformed many oil and natural gas producers over the long term, but the stock price has underperformed over the last year. Click here to read more.Read full newsRead More
Norwegian provided mixed preliminary Q4'22 numbers. The cruise line sector appears poised to follow the airline rebound of 2022 by about 1 year. Read more here.Read full newsRead More
Vital Energy, Inc. reported Q4 2022 production that was above its most recent guidance ranges. Click here to read my analysis of VTLE stock.Read full newsRead More
Chinese sales significantly impact Richemont's quarterly accounts; we believe that this is temporary. China sales are up in January 2023. Read more here.Read full newsRead More
Merck has many divisions and has its most ambitious plans are centered around Oncology, Cardiovascular and Vaccines. Read what investors can expect in 2023.Read full newsRead More
Polaris shares declined since I put out my latest cautious piece. Despite this, the shares are still expensive vs. fundamentals. See more on PII stock here.Read full newsRead More
Citigroup offers a depressed valuation and an interesting dividend yield above 4%. Click here to read my analysis of C stock.Read full newsRead More
Assertio Holdings got rights to Sympazan in October. Most Medicare plans cover it. Click to see what this may mean for the future of ASRT stock.Read full newsRead More
Under Armour's brand issues were apparent in 2016 if you knew where to look. UA hasn't crossed over into fashion, and the sales prove it. Read more here.Read full newsRead More
In this article, I will present my views on where NOT to invest in 2023. Click to see my picks of securities to avoid in 2023.Read full newsRead More
I sold out of Krystal Biotech after it hit my 65% profit price target. I am looking for another opportunity to enter KRYS. Click here to read my KRYS review.Read full newsRead More
Natural gas has plummeted in value in the US and Europe as warm weather and higher production aid supply levels. Read more on UNG ETF here.Read full newsRead More
Las Vegas Sands Corp. shares tend to inch up rather than spike as do many of its peers when bullish news breaks. Click here to read my analysis of LVS stock.Read full newsRead More
The article discusses LHX and PFE - two quite recession-resistant businesses that currently trade at compelling valuations and have solid long-term prospects.Read full newsRead More
Tesla, Inc. is remarkably cheap relative to its revenue growth prospects and earnings growth potential. Click here to read my analysis of TSLA stock.Read full newsRead More
Invesco KBW Premium Yield Equity REIT ETF offers investors an attractive option to invest in small-cap REITs in the U.S. Click here for our review of KBWY ETF.Read full newsRead More
Ally Financial's stock price exploded as the company reported better-than-expected revenues and earnings while expecting a slow-down in deteriorating credit quality.Read full newsRead More